Red cell alloimmunization in chronic renal failure patients undergoing hemodialysis

R. E. Domen; G. Ramirez

doi:10.1159/000184943

Red cell alloimmunization in chronic renal failure patients undergoing hemodialysis

R. E. Domen, G. Ramirez

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

Posttransfusion alloimmunization to red cell antigens was studied in a group of 98 chronic renal disease patients treated solely with hemodialysis. Clinically significant red cell antibodies were formed in only 6.1% of transfused patients, and only 1 patient formed more than one antibody. We do not recommend extended red cell phenotyping, beyond ABO and Rh(D), in patients with end-stage renal disease who may require transfusion.

Original language	English (US)
Pages (from-to)	284-285
Number of pages	2
Journal	Nephron
Volume	48
Issue number	4
DOIs	https://doi.org/10.1159/000184943
State	Published - Jan 1 1988

All Science Journal Classification (ASJC) codes

Physiology
Nephrology
Physiology (medical)
Urology

Access to Document

10.1159/000184943

Cite this

@article{98ed2c5a4439455197b5bc020ffee842,

title = "Red cell alloimmunization in chronic renal failure patients undergoing hemodialysis",

abstract = "Posttransfusion alloimmunization to red cell antigens was studied in a group of 98 chronic renal disease patients treated solely with hemodialysis. Clinically significant red cell antibodies were formed in only 6.1% of transfused patients, and only 1 patient formed more than one antibody. We do not recommend extended red cell phenotyping, beyond ABO and Rh(D), in patients with end-stage renal disease who may require transfusion.",

author = "Domen, {R. E.} and G. Ramirez",

year = "1988",

month = jan,

day = "1",

doi = "10.1159/000184943",

language = "English (US)",

volume = "48",

pages = "284--285",

journal = "Nephron",

issn = "0028-2766",

publisher = "S. Karger AG",

number = "4",

}

TY - JOUR

T1 - Red cell alloimmunization in chronic renal failure patients undergoing hemodialysis

AU - Domen, R. E.

AU - Ramirez, G.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Posttransfusion alloimmunization to red cell antigens was studied in a group of 98 chronic renal disease patients treated solely with hemodialysis. Clinically significant red cell antibodies were formed in only 6.1% of transfused patients, and only 1 patient formed more than one antibody. We do not recommend extended red cell phenotyping, beyond ABO and Rh(D), in patients with end-stage renal disease who may require transfusion.

AB - Posttransfusion alloimmunization to red cell antigens was studied in a group of 98 chronic renal disease patients treated solely with hemodialysis. Clinically significant red cell antibodies were formed in only 6.1% of transfused patients, and only 1 patient formed more than one antibody. We do not recommend extended red cell phenotyping, beyond ABO and Rh(D), in patients with end-stage renal disease who may require transfusion.

UR - http://www.scopus.com/inward/record.url?scp=0023863078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023863078&partnerID=8YFLogxK

U2 - 10.1159/000184943

DO - 10.1159/000184943

M3 - Article

C2 - 3362273

AN - SCOPUS:0023863078

SN - 0028-2766

VL - 48

SP - 284

EP - 285

JO - Nephron

JF - Nephron

IS - 4

ER -

Red cell alloimmunization in chronic renal failure patients undergoing hemodialysis

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this